The composition of microbiota found in the gut influences how susceptible mice are to respiratory virus infections and the severity of these infections, according to researchers from the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State University.
The findings report that segmented filamentous bacteria, a bacterial species found in the intestines, protected mice against influenza virus infection when these bacteria were either naturally acquired or administered.
In this study, the researchers investigated how differences in specific microbial species can impact outcomes of respiratory virus infections and how they might do so, which hasn’t been well defined previously. They studied mice with discrete microbiome differences and mice differing in only the presence or absence of segmented filamentous bacteria. Viral titers in the lung were measured several days after infection and varied significantly depending on the nature of the microbiome of the different animal groups.
“These findings uncover complex interactions that mechanistically link the intestinal microbiota with the functionality of basally resident alveolar macrophages and severity of respiratory virus infection,” said Dr. Andrew Gewirtz.
The study found that in segmented filamentous bacteria-negative mice, basally resident alveolar macrophages were quickly depleted as respiratory virus infection progressed. However, in segmented filamentous bacteria-colonized mice, basally resident alveolar macrophages were altered to resist influenza virus infection depletion and inflammatory signaling.
The basally resident alveolar macrophages disabled influenza virus, in large part by activating a component of the immune system referred to as the complement system.
“We find it remarkable that the presence of a single common commensal bacterial species, amidst the thousands of different microbial species that inhabit the mouse gut, had such strong impacts in respiratory virus infection models and that such impacts were largely attributable to reprogramming of basally resident alveolar macrophages,” said Dr. Richard Plemper, co-senior author of the study, Regents’ Professor and director of the Center for Translational Antiviral Research at Georgia State. “If applicable to human infections, these findings will have major implications for the future risk assessment of a patient to advance to severe disease.”
Sources:
Vu L. Ngo, Carolin M. Lieber, Hae-ji Kang, Kaori Sakamoto, Michal Kuczma, Richard K. Plemper, Andrew T. Gewirtz. Intestinal microbiota programming of alveolar macrophages influences severity of respiratory viral infection. Cell Host & Microbe, 2024; DOI: 10.1016/j.chom.2024.01.002
Georgia State University. “Gut microbiota influence severity of respiratory viral infection.” ScienceDaily. ScienceDaily, 30 January 2024. <www.sciencedaily.com/releases/2024/01/240130133532.htm>.
Materials provided by Georgia State University. Note: Content may be edited for style and length.
Images from:
Photo by Andrea Picquadio
https://www.pexels.com/photo/woman-lying-on-bed-while-blowing-her-nose-3807629